FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 03:42:13 2024-07-12 pm EDT | ||
| 0.24 EUR | +14.29% |
|
| Current month | +56.25% | ||
| 1 month | +108.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.25 | +19.05% |
| 24-07-11 | 0.21 | +10.53% |
| 24-07-10 | 0.19 | +18.75% |
| 24-07-09 | 0.16 | +6.67% |
| 24-07-08 | 0.15 | 0.00% |
Real-time Boerse Frankfurt Warrants
Last update July 12, 2024 at 03:42 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01SZ |
| ISIN | DE000SB01SZ2 |
| Date issued | 2020-06-09 |
| Strike | 225.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.82 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 22.88 € |
|---|---|
| Lowest since issue | 0.052 € |
| Spread | 0.01 € |
| Spread % | 4.00% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.8
USD
Average target price
317.4
USD
Spread / Average Target
-4.06%
- Stock Market
- Certificates
- Certificat
